Litcius/Paper detail

Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Alberta Hoi, Vera Golder, Chak Sing Lau, Aisha Lateef, Yi‐Hsing Chen, Shue‐Fen Luo, Yeong‐Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Shereen Oon, Kristine Ng, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O’Neill, Nicola Tugnet, Annie Law, Sang‐Cheol Bae, Yoshiya Tanaka, Naoaki Ohkubo, Sunil Kumar, Rangi Kandane‐Rathnayake, Mandana Nikpour, Eric F. Morand

2024Annals of the Rheumatic Diseases31 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePrednisoloneInternal medicineTaperingCohortHazard ratioProportional hazards modelFlareGastroenterologyComputer graphics (images)Computer scienceAstrophysicsPhysicsConfidence intervalSystemic Lupus Erythematosus ResearchMultiple Sclerosis Research StudiesAdrenal Hormones and Disorders
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study | Litcius